Bio Pharma Dive
MARCH 16, 2022
Draft recommendations from the agency were generally straightforward, analysts said, although the document emphasized the potential safety risks of gene editing.
World of DTC Marketing
MARCH 16, 2022
The pharma industry’s reputation continues to slip from a pandemic halo-high of 62% in February 2021 to now when fewer than half, just 47%, of people have a favorable view of the industry, according to the Harris Poll’s latest survey. (Source: Endpoints News ) Does anyone believe that pharma cares? Like it or not, the media has had pharma in their crosshair for a long time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 16, 2022
The positive results are the latest evidence supporting a broader role for so-called SGLT2 inhibitors, which started out as diabetes medicines but have since shown promise in a range of metabolic diseases.
Scienmag
MARCH 16, 2022
A challenge in materials design is that in both natural and manmade materials, volume sometimes decreases, or increases, with increasing temperature. While there are mechanical explanations for this phenomenon for some specific materials, a general understanding of why this sometimes happens remains lacking. Credit: Elizabeth Flores-Gomez Murray/Jennifer M.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Patent Watch
MARCH 16, 2022
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Jazz Pharms drug XYREM appeared first on DrugPatentWatch - Make Better Decisions.
XTalks
MARCH 16, 2022
Exact Sciences and long-time colon cancer screening advocate and award-winning journalist Katie Couric have teamed up for Colon Cancer Awareness Month this March in a TV ad for the company’s at-home screening test Cologuard. The ad is part of Exact Sciences’ “Mission to Screen” campaign that was launched this week. The branded campaign includes a TV commercial (linked in the image above) that features Couric cooking dinner with her 30-year-old daughter Ellie as well as snippets of her conversati
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
MARCH 16, 2022
Patients who were bedridden for seven days or longer were at increased risk of depression and anxiety over the study period
Scienmag
MARCH 16, 2022
Newswire hacker case reveals how traders with private information make choices Credit: Rotman School of Management Newswire hacker case reveals how traders with private information make choices Illegal traders looked for similar hard and soft signals, shows new study Toronto – A group of Russian and Ukrainian cyber-hackers were clearly risk-takers. But their actions after […].
Outsourcing Pharma
MARCH 16, 2022
An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.
Scienmag
MARCH 16, 2022
Noble metals have been widely used as heterogeneous catalysts because they easily stand out with high activity and selectivity for many reactions of both scientific and industrial interest. At least a century ago, some light alloying elements with small atomic radii are known to easily permeate into the interstitial location of metal lattice. The catalytic […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Outsourcing Pharma
MARCH 16, 2022
While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.
Scienmag
MARCH 16, 2022
Wireless sensors can monitor how temperature, humidity or other environmental conditions vary across large swaths of land, such as farms or forests. Credit: Mark Stone/University of Washington Wireless sensors can monitor how temperature, humidity or other environmental conditions vary across large swaths of land, such as farms or forests. These tools could provide unique insights […].
Pharma Times
MARCH 16, 2022
Better treatment for conditions experienced by individuals who were exposed to alcohol before birth
Scienmag
MARCH 16, 2022
The first large-scale trial to test the long-term effects of a cocoa flavanol supplement to prevent cardiovascular disease offers promising signals that cocoa flavanols could have protective cardiovascular effects. In papers published in The American Journal of Clinical Nutrition, a team led by Howard Sesso, ScD, MPH, and JoAnn Manson, MD, DrPH, both of the […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Outsourcing Pharma
MARCH 16, 2022
A leader from the patient recruitment specialist discusses the industryâs ongoing challenges with patient population diversity, and potential solutions.
Scienmag
MARCH 16, 2022
Biological processes such as wound healing and cancer cell invasion rely on the collective and coordinated motion of living cells. A little understood aspect that influences these processes is the pressure differences within and between different parts of the body. Researchers from Göttingen University and Münster University designed model tumour systems using cervical cancer cells […].
Pharma Tutor
MARCH 16, 2022
ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP. About Author. Meenu Maurya. Email : meenudinesh15@gmail.com. admin. Wed, 03/16/2022 - 15:06. Tags. Articles.
Scienmag
MARCH 16, 2022
New Rochelle, NY, March 16, 2022—Based on data from more than 400 twins, researchers used multi-omics data integration to develop a model for predicting blood pressure values. Their research is described in the peer-reviewed OMICS: A Journal of Integrative Biology. Click here to read the article now. Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, March […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Roots Analysis
MARCH 16, 2022
Over the years, applications of exosomes in therapeutics have undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Moreover, various startups and small firms have entered into collaborations in order to advance their innovations and offer specialized research expertise, services and technologies.
Scienmag
MARCH 16, 2022
Woods Hole, MA (March 16, 2022) – Most research operations and missions require winches for hauling and retrieving equipment over the side of ships. A winch is used to hoist items to and from the deck such as nets, vehicles and other scientific equipment. Typically, marine winches in use today have large on-deck footprints, can […].
pharmaphorum
MARCH 16, 2022
Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca’s top-selling respiratory drug Symbicort, although launch plans remain uncertain for now. Viatris’ generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been cleared for the same indications as the brand, namely maintenance treatment for asthma
Scienmag
MARCH 16, 2022
Reston, VA—A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by The Journal of Nuclear Medicine. The comprehensive literature review of molecular imaging findings sheds light on how COVID-19 affects the brain and identifies important implications for other neurological conditions, like Parkinson’s disease or […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
pharmaphorum
MARCH 16, 2022
Merck & Co’s two powerhouse oncology drugs – Keytruda and Lynparza – have failed to show efficacy when used in combination for patients with previously treated metastatic castration-resistant prostate cancer (mCRPC). The disappointing result comes from the KEYLYNK-010 trial, which looked at the combination of PD-1 inhibitor Keytruda (pembrolizumab) with AstraZeneca-partnered PARP inhibitor Lynparza (olaparib) in men whose cancer had progressed after chemotherapy and anti-androgen thera
Scienmag
MARCH 16, 2022
The University of North Carolina Lineberger Comprehensive Cancer Center’s 45th annual scientific symposium on April 18-19, 2022, will feature 14 talks addressing the central theme: The biology of aggressive cancers and tumor-stroma interactions.” The scientific meeting is free and it will take place in Chapel Hill, NC. It also will be streamed online for those […].
The Pharma Data
MARCH 16, 2022
ADUHELM continued to reduce two key Alzheimer’s disease pathologies, amyloid beta plaques and p-tau181, in patients treated for up to two and a half years Data from both Phase 3 studies also show that clinical decline was reduced in participants who had plasma p-tau181 reduction at 78 weeks These data further inform the scientific evidence for amyloid as a surrogate biomarker and the importance of continuation of treatment.
Scienmag
MARCH 16, 2022
How the lower jaw — mandible — develops and consequently how and why some developmental birth defects occur is the focus of a five-year, $2.8 million grant to Joan Richtsmeier, distinguished professor of anthropology, Penn State, from the National Institutes of Health’s National Institute of Dental & Craniofacial Research. Credit: Joan T. Richtsmeier, Penn State […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The Pharma Data
MARCH 16, 2022
Biogen Inc. (Nasdaq: BIIB) announced that The Journal of Prevention of Alzheimer’s Disease (JPAD) today published a peer-reviewed manuscript detailing data from the pivotal Phase 3 EMERGE and ENGAGE trials for ADUHELM ® (aducanumab-avwa) 100 mg/mL injection for intravenous use in early Alzheimer’s disease. The publication includes results from the primary, secondary and tertiary endpoints in the trials, as well as safety data and biomarker sub-studies.
Scienmag
MARCH 16, 2022
EL PASO, Texas (March 16, 2022) — Jorge Muñoz, Ph.D., assistant professor of physics at The University of Texas at El Paso, has been named a 2022 Cottrell Scholar by the Research Corporation for Science Advancement. Credit: UTEP Marketing and Communications. EL PASO, Texas (March 16, 2022) — Jorge Muñoz, Ph.D., assistant professor of physics […].
The Pharma Data
MARCH 16, 2022
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta The World Health Organization (WHO) has recently reported that the BA.2 subvariant is steadily increasing in prevalence, specifically in Denmark Use of these tests assess the spread of circulating variants and can help monitor the potential impact of therapeutics, vaccines and public health interventions All R
Scienmag
MARCH 16, 2022
Scientists from the Nanyang Technological University, Singapore (NTU Singapore) and the Korea Institute of Machinery & Materials (KIMM) have developed a technique to create a highly uniform and scalable semiconductor wafer, paving the way to higher chip yield and more cost-efficient semiconductors. Credit: NTU Singapore Scientists from the Nanyang Technological University, Singapore (NTU Singapore) and […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
324 
Let's personalize your content